Hennessy K, Fennewald S, Kieff E
Proc Natl Acad Sci U S A. 1985 Sep;82(17):5944-8. doi: 10.1073/pnas.82.17.5944.
Most sera from patients with rheumatoid arthritis as well as some sera from normal Epstein-Barr virus (EBV)-infected people detect a 140-kDa protein on immunoblots of EBV-infected lymphoblasts. The 140-kDa protein is a nuclear protein characteristic of latent EBV infection. Sera reactive with this protein identify a distinctive globular nuclear antigen. Although the 140-kDa protein is encoded by EBV, it is not encoded by genes that encode the two previously described EBV nuclear antigens (EBNA) or the latent-infection membrane protein. The 140-kDa protein is therefore designated EBNA3. The EBV genes, including the gene encoding EBNA3, that are characteristically expressed in latent infection are likely to play a role in the maintenance of persistent latent viral infection or in the cell proliferation caused by virus infection.
大多数类风湿性关节炎患者的血清以及一些感染了爱泼斯坦-巴尔病毒(EBV)的正常人血清,在EBV感染的淋巴母细胞免疫印迹上可检测到一种140 kDa的蛋白质。该140 kDa蛋白质是EBV潜伏感染的一种核蛋白特征。与这种蛋白质反应的血清可识别一种独特的球状核抗原。虽然140 kDa蛋白质由EBV编码,但它并非由编码先前描述的两种EBV核抗原(EBNA)或潜伏感染膜蛋白的基因所编码。因此,140 kDa蛋白质被命名为EBNA3。在潜伏感染中特征性表达的EBV基因,包括编码EBNA3的基因,可能在维持持续性潜伏病毒感染或病毒感染引起的细胞增殖中发挥作用。